Neuralink's Clinical Trial Approval in Canada
Neuralink, Elon Musk's brain-computer interface startup, received approval from Health Canada for its first clinical trial allowing individuals with paralysis to control devices using their thoughts. It aims to restore autonomy by enabling users to control digital devices through thought alone.
Key Points
- Approval from Health Canada for Neuralink's first clinical trial
- Focus on evaluating safety and functionality of the implant for people with quadriplegia
- Implant aims to allow users to control digital devices through thought alone
- University Health Network hospital in Toronto selected for neurosurgical procedures
Pros
- Enables individuals with paralysis to control external devices using their thoughts
- Restores autonomy for users with quadriplegia through thought-controlled digital devices
Cons
- Controversy surrounding the death of approximately 1,500 animals during experiments since 2018